How Canadian Oncologists Use Oncotype DX for Treatment of Breast Cancer Patients

od Zhu, Xiaofu, Dent, Susan, Paquet, Lise, Zhang, Tinghua, Tesolin, Daniel, Graham, Nadine, Aseyev, Olexiy, Song, Xinni
Wydane w Curr Oncol (2021)

Right heart function deteriorates in breast cancer patients undergoing anthracycline-based chemotherapy

od Boczar, Kevin Emery, Aseyev, Olexiy, Sulpher, Jeffrey, Johnson, Christopher, Burwash, Ian G, Turek, Michele, Dent, Susan, Dwivedi, Girish
Wydane w Echo Res Pract (2016)

Cost-Effectiveness Analysis of 12-Versus 4-Weekly Administration of Bone-Targeted Agents in Patients with Bone Metastases from Breast and Castration-Resistant Prostate Cancer

od Tu, Megan M., Clemons, Mark, Stober, Carol, Jeong, Ahwon, Vandermeer, Lisa, Mates, Mihaela, Blanchette, Phillip, Joy, Anil Abraham, Aseyev, Olexiy, Pond, Gregory, Fergusson, Dean, Ng, Terry L., Thavorn, Kednapa
Wydane w Curr Oncol (2021)

A randomised trial of 4- versus 12-weekly administration of bone-targeted agents in patients with bone metastases from breast or castration-resistant prostate cancer

od Clemons, Mark, Ong, Michael, Stober, Carol, Ernst, Scott, Booth, Christopher, Canil, Christina, Mates, Mihaela, Robinson, Andrew, Blanchette, Phillip, Joy, Anil Abraham, Hilton, John, Aseyev, Olexiy, Pond, Gregory, Jeong, Ahwon, Hutton, Brian, Mazzarello, Sasha, Vandermeer, Lisa, Kushnir, Igal, Fergusson, Dean
Wydane w Eur J Cancer (2021)